Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-03 · accession 0001522780-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-05 | 2025-12-03 | STOK | Kaye Edward M. MD | Dir | M - OptEx | $0.00 | +26.2K | 77.6K | +51% | $0 |
| DM | 2025-12-05 | 2025-12-04+ | STOK | Kaye Edward M. MD | Dir | S - Sale+OE | $31.13 | -15.0K | 71.1K | -17% | -$466.9K |
| D | 2025-12-05 | 2025-12-03 | STOK | Kaye Edward M. MD | Dir | M - OptEx | $0.00 | -26.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-03 | M | A | 26,250 | $0.00 | 77,555 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-04 | S | D | 5,222 | $30.76 | 72,333 | D | — | — | (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.23 to $31.19 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3, 4, 6, and 7 of this Form 4. |
| 3 | Common | Common Stock | 2025-12-05 | S | D | 500 | $31.85 | 62,554 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.70 to $31.96 per share, inclusive. |
| 4 | Common | Common Stock | 2025-12-05 | S | D | 6,367 | $31.33 | 64,735 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.93 to $31.69 per share, inclusive. |
| 5 | Common | Common Stock | 2025-12-05 | S | D | 1,681 | $31.15 | 63,054 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.69 to $31.61 per share, inclusive. |
| 6 | Common | Common Stock | 2025-12-04 | S | D | 1,231 | $31.32 | 71,102 | D | — | — | (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.23 to $31.505 per share, inclusive. |
| 7 | Derivative | Performance Stock Units | 2025-12-03 | M | D | 26,250 | $0.00 | 0 | D | — · — to 2025-12-03 | 26,250 Common Stock | (F8) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F9) Half the award vested on December 3, 2024 and the remainder vested or vests on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date. |